[Long-term outcome of the adult onset craniopharyngiomas]

Ann Endocrinol (Paris). 2007 Jun;68(2-3):186-90. doi: 10.1016/j.ando.2007.04.001. Epub 2007 May 25.
[Article in French]

Abstract

There is few published series dealing on the long-term outcome of the adult-onset craniopharyngiomas. We report the long term clinical, tomodensitometric and MRI data outcome of 35 (23 woman and 12 men) consecutive adult-onset cured for craniopharyngiomas between 1983 and 2002, and followed-up in Rennes University Hospital. The operation was performed via frontopterional approach in 59% and transphenoïdal approach in 41% of cases. Their age at the time of diagnosis was 44.7+/-15.1 years (21-74). The average postoperation follow-up was 7.4+/-7.0 years (0.1-19.1). Recurrence of tumour occurred in 8 patients (25.8%) and a tumor progression in 1 case. The delay of recurrence after initial surgery was 4.1+/-1.3 years (1.4-6.3). Two patients had 5 and 6 years treatment by growth hormone (GH), without tumor recurrence. The observed increase of weight after the surgical cure of craniopharyngiomas concerned 22 patients (63%). The average weight gain was 17.5+/-14.7 kg (1.5-58). In 7 cases (20%) neuropsychological disorders were noted, of which 2 with lost of professional activity. Three patients died. In conclusion the craniopharyngiomas recurrence is frequent and can appear in very prolonged deadlines after the initial surgery.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Craniopharyngioma / surgery
  • Craniopharyngioma / therapy*
  • Female
  • Follow-Up Studies
  • Growth Hormone / therapeutic use
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Mental Disorders / etiology
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Pituitary Neoplasms / surgery
  • Pituitary Neoplasms / therapy*
  • Survival Analysis
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Growth Hormone